Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With CD19-TriCART Cell Therapy
Clinical trial NCT03720496 · UNKNOWN
Trial details
- NCT number
- NCT03720496
- Sponsor
- Timmune Biotech Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2021-06-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.